Nicholas Restifo

Company: Lyell Immunopharma Inc.

Job title: Cancer immunotherapy Explorer

Seminars:

Enhancing Stemness of Polyclonal T Cells to Improve Anti-Tumor Activity 9:30 am

• Yielding highly effective polyclonal T cell products by utilizing next generation strategies including gene editing • Enriching for tumor-specific T cell clonotypes in clinical T cell products to improve therapeutic efficacy • Emerging approaches to maximize clinical utility of TIL productsRead more

day: Day One